Emine Akdemir

Mar 8, 2023 | bmjopen.bmj.com | Maike G. Sweegers |Alina Vrieling |Helene Rundqvist |Emine Akdemir

Methods and analysisThe ENHANCE study is a multicentre, open label, two-arm randomised controlled trial. Patient inclusion and data collection started in August 2022. Ethical approval, extending to all participating centres, was granted by the Medical Ethical Committee NedMec (Amsterdam, The Netherlands), under reference number 22–595/NL78792.031.22. The trial is prospectively registered in Clinical Trials on 29 July 2022.